ARNA Insider Trading Activity and SEC Form 4 Filings
ARNA insider trading summary
No open-market insider purchases or sales of Arena Pharmaceuticals Inc (ARNA) have been reported on SEC Form 4 in the past 12 months.
Latest ARNA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 16, 2021 | Amit Munshi | President and CEO | Buy | $48K (1,000 @ $48.19) |
| Aug 12, 2021 | Amit Munshi | President and CEO | Buy | $50K (1,000 @ $50.41) |
| Aug 10, 2021 | Amit Munshi | President and CEO | Buy | $53K (1,000 @ $52.91) |
| Aug 3, 2021 | Robert Lisicki | EVP, Chief Commercial Officer | Sell | $335K (5,605 @ $59.84) |
| Aug 3, 2021 | Robert Lisicki | EVP, Chief Commercial Officer | Sell | $716K (11,895 @ $60.20) |
| Jun 15, 2021 | Jayson Donald Alexander Dallas | Director | Sell | $81K (1,223 @ $66.36) |
| Feb 16, 2021 | Vincent Aurentz | Executive VP and CBO | Sell | $215K (2,524 @ $85.00) |
| Feb 2, 2021 | Robert Lisicki | EVP, Chief Commercial Officer | Sell | $135K (1,741 @ $77.70) |
| Feb 2, 2021 | Robert Lisicki | EVP, Chief Commercial Officer | Sell | $502K (6,400 @ $78.50) |
| Feb 2, 2021 | Robert Lisicki | EVP, Chief Commercial Officer | Sell | $743K (9,359 @ $79.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.